News Archives | Alira Health

Home > Education Hub > News

We have acquired CROS NT, a data-driven Contract Research Organization (CRO) headquartered in Italy with offices across Europe and the United States. CROS NT provides high quality,(...)

MedTech

News April 28, 2021

Alira Health and Science Center Establish Strategic Partnership to Accelerate MedTech Commercialization

Alira Health is proud to announce their new partnership with University City Science Center, a Philadelphia-based nonprofit with over 60 years of experience advancing the commercialization(...)

M&A MedTech Pharma

News April 12, 2021

Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev

Alira Health strengthens its growth strategy with a $35M funding, led by Creadev.

Research & Development

News March 15, 2021

Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical

BOSTON, USA – Alira Health (www.alirahealth.com), a leading international healthcare and life sciences advisory firm, is pleased to announce that Nikole Siegmund has joined the firm(...)

MedTech Pharma

News February 4, 2021

2020 Year in Review

With 2021 in full swing, we want to take a moment to reflect on last year’s achievements and congratulate the entire Alira Health Team for their hard work and dedication to healthcare(...)

Regulatory

News February 2, 2021

We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System

We are proud to announce the firm’s Regulatory practice has secured a Breakthrough Device Designation from FDA for the real-time tissue perfusion system, PEDRA Xauron Perfusion System.

Patient Engagement

News January 26, 2021

Alira Health Welcomes Annabel de Maria, Vice President, Patient Engagement

We are pleased to announce that Annabel de Maria has joined the firm as Vice President, Patient Engagement.

Latest from Alira Health

Regulatory

Events July 20, 2021

Alira Health Webinar Replay: Trends and Challenges in US and EU Combination Product Landscapes

Rewatch this timely webinar with Alira Health’s Regulatory leadership team featuring key insights and advice for U.S. and EU companies as they map out their own regulatory pathways(...)

Regulatory

Publications July 20, 2021

Infographic: The Pre-IND to Market Approval Roadmap in the U.S.

Download our latest infographic, The Pre-IND to Market Approval Roadmap in the U.S.

Research & Development

Publications June 9, 2021

EU Supply Integrity Guidelines

Check out Alira Health's latest publication, “EU Supply Integrity Guidelines”. In the document, best practices for European distribution and supply integrity management are highlighted(...)

MedTech

Publications June 2, 2021

Infographic: U.S. Go-to- Market Strategy Design for Wearable Technology in Healthcare

When our client, a European healthcare-based startup developing wrist wearables wanted to expand to the U.S., the Alira Health team helped develop a go-to-market strategy for this new segment.

View all Events

Our locations around the globe

USA, Boston

1 Grant Street, Suite 400, Framingham, Boston,
MA 01702, USA
+1 (774) 777 5255

USA, North Carolina

1340 Environ Way, 3rd Floor,
Chapel Hill,
NC 27517, USA
+1 919-929-5015
+1 919-928-9320

USA, San Francisco

San Francisco,
CA 94108, USA
+1 (774) 777 5255

France, Paris

12 Rue Charlot
75003 Paris, France
+33 (0)9 72 16 55 57

Germany, Munich

Kurfürstenstraße 22
80801 Munich, Germany
+49 (89) 416 14 22-0

Italy, Verona

Via Germania 2
37136 Verona, Italy
+39 045 820 26 66
+39 045 820 58 75

Italy, Bologna

Galleria Guglielmo Marconi 2
(all’altezza di Via Guglielmo Marconi 29)
40122 Bologna, Italy

Italy, Milan

Via Carlo Ottavio
Cornaggia 10
20123 Milan, Italy

Spain, Barcelona

Carrer de Balmes, 206 – Ático 2 08006 Barcelona, Spain
+34 (0)93 737 65 70

UK, Milton Keynes

Fairbourne Drive,
Atterbury Lakes,
Milton Keynes,
MK10 9RG, United Kingdom
+44 (0)1908 488787

Switzerland, Geneva

Campus Biotech Innovation Park
Avenue de Sécheron 15
1202 Geneva, Switzerland
+41 (0)61 205 9669

Switzerland, Basel

Badenstrasse 3
4057 Basel, Switzerland
+41 (0)61 205 9669

Alira Health Welcomes Fredrik Nyberg as Partner and Regional Head

Alira Health Announces its Role as Strategic Advisor to Naxicap

Alira Health Expands Its Global Clinical and Data Capabilities Through the Acquisition of CROS NT

Alira Health and Science Center Establish Strategic Partnership to Accelerate MedTech Commercialization

Alira Health Strengthens its Growth Strategy with a $35M Funding, led by Creadev

Alira Health Welcomes Nikole Siegmund, Vice President, Preclinical

2020 Year in Review

We Secured Breakthrough Device Designation from FDA on PEDRA Xauron Perfusion System

Alira Health Welcomes Annabel de Maria, Vice President, Patient Engagement

Latest from Alira Health

Webinar Recap: Risk Management & Regulatory Submissions

Event: Cardio Wearables 2021 Conference

Event: MTAA Value Based Procurement Webinar & Conference

Alira Health’s Transformation Talks: Creating a lifecycle of Patient Engagement

Managing Relationships Between CROs and Clinical Trial Sites

Alira Health Webinar Replay: Trends and Challenges in US and EU Combination Product Landscapes

Infographic: The Pre-IND to Market Approval Roadmap in the U.S.

EU Supply Integrity Guidelines

Infographic: U.S. Go-to- Market Strategy Design for Wearable Technology in Healthcare

Our locations around the globe